Translational Development Acquisition (TDAC) Non Operating Investment Income (2024)
Translational Development Acquisition's (TDAC) quarterly Non Operating Investment Income came in at $125346.0 in Q4 2024.
Translational Development Acquisition (TDAC) Non Operating Investment Income (2024) Analysis & Trends
Translational Development Acquisition (TDAC) has 1 years of Non Operating Investment Income data on file, last reported at $125346.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | - |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | - |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | - |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | - |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | - |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | -36,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 125,346.00 |
| Dec 31, 2024 | 125,346.00 |